Presentation

Identification and development of a 1st in class naturally-derived protein that drives mucosal healing and is orally delivered by an engineered cellular therapy targeting the gastro-intestinal tract

May 24, 2022

Discovering immunomodulatory microbiome-derived peptides with therapeutic potential through multi-technology meta-analysis and functional assays

May 24, 2022

Targeting the CXCR3 pathway with a novel peptide drug candidate mobilizes the immune system to enhance anti-tumor immunity

April 11, 2022

Identification and development of a 1st in class naturally-derived protein that drives mucosal healing and is orally delivered by an engineered cellular therapy targeting the gastro-intestinal tract

January 20, 2022

1st In Class Naturally Derived Protein That Directly Improves Mucosal Healing and is Delivered Directly to the Gut by an Engineered Lactococcus lactis Expression System

January 16, 2022

1st In Class Naturally Derived Protein That Directly Improves Mucosal Healing Delivered Directly to the Gut by an Engineered Lactococcus lactis Expression System

December 15, 2021

A novel microbiome-derived peptide, SG-3-00802 reverses resistance to anti-programmed cell death protein-1 (PD-1) therapy by modulating chemokine receptor signaling

November 1, 2021

Biotech Showcase Digital 2021 Conference

January 4, 2021